Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.
about
Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxExpression of IL-18, IL-18 binding protein, and IL-18 receptor by normal and cancerous human ovarian tissues: possible implication of IL-18 in the pathogenesis of ovarian carcinoma.Tobacco exposure by various modes may alter proinflammatory (IL-12) and anti-inflammatory (IL-10) levels and affects the survival of prostate carcinoma patients: an explorative study in North Indian population.Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studiesThe -607C/A polymorphisms in interleukin-18 gene promoter contributes to cancer risk: evidence from a meta-analysis of 22 case-control studies.Tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in north Indian population.Activation of estrogen receptor-alpha by the anion nitrite.Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.Cytokines as potential tumour markers.The oncolytic virus ΔPK has multimodal anti-tumor activity.Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.Adult-onset Still's disease-like manifestation accompanied by the cancer recurrence after long-term resting state.IL-18 is produced by prostate cancer cells and secreted in response to interferons.Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan
P2860
Q28477021-C20D39C9-F36B-4ACC-9CC5-EAEEC9E1B3ABQ33735958-252BC1AD-9C47-4DE7-9FD5-394DB589BB68Q34080207-84D66921-5A51-48B9-AE75-FF340ABD13C4Q34997059-62A69AB3-D7A4-4F6B-B8C5-07932691EEE5Q35018627-856121FE-91B2-4A24-BB50-BED25028AB44Q36495395-E6586C63-8994-4B3B-9FB1-69A474DC46B2Q36913906-801ABAC5-6287-4C27-BFEC-1370DA5E97A1Q37632854-C971BBED-D282-4759-8ECA-81EF6F7927AAQ38089767-48923CBC-86F6-4273-9E5E-BC63CFC0A31EQ38848885-17D3B0E2-4E78-400B-9E3A-0EB25F8951E3Q38959951-5CD80E80-CC5A-49D2-9963-D0B2B34F3E7DQ39416564-72B3693D-2228-4B21-9E41-3E8B92C88087Q40079995-88407EE3-8FCF-4AA6-8233-D13BDF4BC7C9Q44549275-FD63EFF8-3AFF-4896-A809-8098D2372102Q45024315-AAE253C6-BDCE-46A5-BED2-F68CDA3277C1Q53445811-55824A8F-670A-4328-BB1C-240EA353CE6FQ54471401-418C067A-E588-4045-822E-A4F47D3458D3Q59125989-E5DB7A6C-4015-40AB-A6A0-A140F4ED2EDD
P2860
Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Clinical importance of serum i ...... in breast carcinoma patients.
@en
Clinical importance of serum i ...... in breast carcinoma patients.
@nl
type
label
Clinical importance of serum i ...... in breast carcinoma patients.
@en
Clinical importance of serum i ...... in breast carcinoma patients.
@nl
prefLabel
Clinical importance of serum i ...... in breast carcinoma patients.
@en
Clinical importance of serum i ...... in breast carcinoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Clinical importance of serum i ...... in breast carcinoma patients.
@en
P2093
Banu Sancak
Nazan Günel
Oğuz Hasdemir
Sükrü Bozkurt
Uğur Coşkun
Uğur Günel
P2860
P304
P356
10.1002/CNCR.10705
P407
P577
2002-08-01T00:00:00Z